Dearborn Partners’s Allergan Inc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-9,893
Closed -$2.1M 304
2014
Q4
$2.1M Sell
9,893
-525
-5% -$104K 0.19% 113
2014
Q3
$1.86M Buy
10,418
+762
+8% +$127K 0.18% 127
2014
Q2
$1.63M Sell
9,656
-25
-0.3% -$3.89K 0.16% 130
2014
Q1
$1.2M Sell
9,681
-1,471
-13% -$179K 0.13% 154
2013
Q4
$1.24M Buy
11,152
+675
+6% +$64.5K 0.14% 152
2013
Q3
$948K Buy
10,477
+600
+6% +$53.9K 0.12% 162
2013
Q2
$832K Buy
+9,877
New +$1.02M 0.12% 167

Other funds holding AGN

Dearborn Partners's AGN Position: Q1 2015 in Review

Dearborn Partners sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 9,893 shares — an estimated $2.1M sold.

Dearborn Partners first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $2.1M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Dearborn Partners reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Dearborn Partners sold 9,893 Allergan Inc shares in Q1 2015, an estimated $2.1M.
  • Dearborn Partners first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Dearborn Partners's Allergan Inc position peaked at $2.1M in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Dearborn Partners's 13F filing for Q1 2015, filed 21 Apr 2015.